Sign in

NCT05141695Completed

Evaluation of the Effect of Repetitive Peripheral Magnetic Stimulation on Upper Extremity Spasticity After Stroke

Evaluation of the Effect of Repetitive Peripheral Magnetic Stimulation With Shearwave Ultrasound Elastography in Upper Extremity Spasticity After Stroke: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 29 Jan 2025

Brief summary (registry, in English)

Spasticity is a frequent problem in post-stroke patients. It can negatively affect the functional recovery of patients and impair their quality of life. The repetitive pulsed magnetic stimulation (rPMS) treatment has been shown to cause a reduction in muscle tone and improvement in activities of daily living in stroke patients. So far, the effects of rPMS on muscle tone, which is the neurophysiological component of spasticity, have been evaluated, but its effects on the biomechanical component (soft tissue stiffness) have not been demonstrated. In this study, the effects of rPMS on soft tissue stiffness as well as increased muscle tone will be evaluated with clinical and ultrasound elastography in post-stroke patients with upper extremity spasticity.

Status (registry)
Completed
Study type
Interventional
Enrollment
48 (actual)
First submitted
24 Nov 2021
Start date
1 Apr 2022
Primary completion date
15 Jun 2024
Lead sponsor
Ankara University
Diseases
Stroke
NCT number
NCT05141695

What you commit to

  • Study type: Interventional
  • Participants enrolled: 48
  • From 1 Apr 2022 to the primary completion date, 15 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients treated with botulinum toxin, phenol, alcohol injection for spasticity in the last 6 months
  • Patients who have previously undergone antispastic surgery to the treatment area
  • Patients with a change in oral antispastic drug use in the last 6 months
  • Patients with metal implants in the treatment area

Other illness

  • Patients with bleeding diathesis
  • Patients with implanted devices (cardiac pacemaker, cochlear implant, drug pumps)
  • Patients with vascular problems such as deep vein thrombosis, phlebitis, varicose veins, arterial disease
  • Patients with a history of cancer in the treatment area

Other

  • Patients with fixed contractures in the elbow and wrist
  • Patients with signs of acute inflammation in the treatment area
  • Pregnancy
  • Patients with nonunion fractures at the treatment site

Who the study is looking for

  • Being diagnosed with stroke according to the definition of the World Health Organization (1989)
  • Being over 18 years old
  • Having a stroke confirmed by Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)
  • Patients with spasticity between grade 1 and 3 according to the Modified Ashworth Scale (MAS) in the upper extremity arm/forearm muscle
  • Wellness of the patient's general condition after stroke

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Ankara University Faculty of Medicine, Cebeci Hospital, Neurorehabilitation Clinic
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.